- Home
- CYCC vs AEVAW Comparison
CYCC vs AEVAW Comparison
Compare CYCC & AEVAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- AEVAW
- Stock Information
- Founded
- CYCC 1992
- AEVAW N/A
- Country
- CYCC United States
- AEVAW United States
- Employees
- CYCC N/A
- AEVAW N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- AEVAW Auto Parts:O.E.M.
- Sector
- CYCC Health Care
- AEVAW Consumer Discretionary
- Exchange
- CYCC Nasdaq
- AEVAW Nasdaq
- Market Cap
- CYCC 3.6M
- AEVAW 4.0M
- IPO Year
- CYCC N/A
- AEVAW N/A
- Fundamental
- Price
- CYCC $0.34
- AEVAW $0.07
- Analyst Decision
- CYCC Strong Buy
- AEVAW
- Analyst Count
- CYCC 1
- AEVAW 0
- Target Price
- CYCC $11.00
- AEVAW N/A
- AVG Volume (30 Days)
- CYCC 404.4K
- AEVAW N/A
- Earning Date
- CYCC 03-18-2025
- AEVAW N/A
- Dividend Yield
- CYCC N/A
- AEVAW N/A
- EPS Growth
- CYCC N/A
- AEVAW N/A
- EPS
- CYCC N/A
- AEVAW N/A
- Revenue
- CYCC $74,000.00
- AEVAW N/A
- Revenue This Year
- CYCC N/A
- AEVAW N/A
- Revenue Next Year
- CYCC $88.68
- AEVAW N/A
- P/E Ratio
- CYCC N/A
- AEVAW N/A
- Revenue Growth
- CYCC N/A
- AEVAW N/A
- 52 Week Low
- CYCC $0.30
- AEVAW N/A
- 52 Week High
- CYCC $4.00
- AEVAW N/A
- Technical
- Relative Strength Index (RSI)
- CYCC 46.57
- AEVAW N/A
- Support Level
- CYCC $0.32
- AEVAW N/A
- Resistance Level
- CYCC $0.38
- AEVAW N/A
- Average True Range (ATR)
- CYCC 0.02
- AEVAW 0.00
- MACD
- CYCC 0.00
- AEVAW 0.00
- Stochastic Oscillator
- CYCC 50.00
- AEVAW 0.00
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.